Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.
Writing Committee for the Pediatric Eye Disease Investigator Group; Hartnett ME, Wallace DK, Dean TW, Li Z, Boente CS, Dosunmu EO, Freedman SF, Golden RP, Kong L, Prakalapakorn SG, Repka MX, Smith LE, Wang H, Kraker RT, Cotter SA, Holmes JM.
Writing Committee for the Pediatric Eye Disease Investigator Group, et al. Among authors: wang h.
JAMA Ophthalmol. 2022 Apr 1;140(4):337-344. doi: 10.1001/jamaophthalmol.2022.0030.
JAMA Ophthalmol. 2022.
PMID: 35446359
Free PMC article.